Categories

Trending News + Events

MiraVista – VetGirl

MiraVista – VetGirl

Dr. Andrew Hanzlicek presented a 1-hour webinar on VetGirl, discussing clinical review of antifungal treatment recommendations for common invasive fungal infections in dogs and cats, including blastomycosis, histoplasmosis, coccidioidomycosis, cryptococcosis, and opportunistic molds. View this webinar for  free until April 24th, 2021 and learn more about what the future holds for antifungal therapies in veterinary...
Read More →
Posaconazole and Voriconazole –  Treating Invasive Fungal Infections in Small Animals

Posaconazole and Voriconazole – Treating Invasive Fungal Infections in Small Animals

Background Posaconazole and voriconazole are next generation azoles most closely related to itraconazole and fluconazole, respectively. As compared with the prior generation azoles, posaconazole and voriconazole are more active against molds (Asper) and yeasts (Crypto) with good activity against enzootic dimorphic fungi (Blasto, Histo, Cocci). They are approved by the FDA for the prevention (posa-)...
Read More →
CUSTOMER & TECHNICAL SERVICE UPDATE

CUSTOMER & TECHNICAL SERVICE UPDATE

MiraVista has created a summary of recommendations from the current literature on diagnosis and treatment of blastomycosis. This brief serves as a reference for information regarding background, clinical findings, diagnosis, treatment and monitoring for blastomycosis. Contributors include Drs. Joe Wheat, Janelle Renschler, and Heather Largura.
MiraVista Sponsors Veterinary Continuing Education Seminar in Milwaukee

MiraVista Sponsors Veterinary Continuing Education Seminar in Milwaukee

MiraVista is sponsoring a veterinary continuing education seminar in Milwaukee, Wisconsin on September 27, 2018. The topic is Getting the Most from Your Lab Work. Attendees can earn 1.5 hours of CE credit through the Milwaukee Veterinary Medical Association (MVMA). Veterinary Continuing Education This seminar is part of a veterinary continuing education (CE) program hosted...
Read More →
Contact Us
CREDENTIALS:
CREDENTIALS: